NEW YORK (AP) - Pfizer said Friday that its drug Torisel failed to help patients with a form of advanced kidney cancer when combined with Roche's drug Avastin.
The study compared renal cell carcinoma patients taking the Torisel-Avastin combination to those taking Avastin plus another cancer drug.
Patients taking the Pfizer combination did not show slower disease progression than those in the other group. Pfizer said.
Torisel is already approved as a stand-alone treatment for advanced renal cell carcinoma.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
A shooting on Lafayette's south side is under investigation.
It's been nearly a month since a tornado damaged Southwestern Middle School and Mintonye Elementary School, giving faculty the task of helping students transition to their new surroundings.
Donations are being accepted to help around 300 seniors receive a holiday gift.